ConditionGlioblastoma
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorCentre Paul Strauss
About this trial
The aim of this study is to determine whether the diffuse cerebral metabolic disturbances observed in glioblastoma are exclusively linked to the direct and indirect effects of tumor infiltration (particularly structural disconnection), or whether they also reflect a more global alteration of neurometabolic and neurovascular coupling mechanisms.
This approach thus aims to better understand the pathophysiological basis of cognitive impairment in glioblastoma and to characterize the impact of the disease at the level of brain networks.
Eligibility criteria
Qualifiers
Adult patients
Patients with glioblastoma
Preoperative metabolic evaluation of a brain-expanding lesion
Disqualifiers
Contraindications to MRI
Minor or incapacitated adult
Patient deprived of liberty
Patient under legal guardianship
Trial design
Treatments tested in this trial
- 18F-FDG PET/MRI with additional DTI and rs-fMRI sequences
Treatment groups
80 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov